Tag: sunvozertinib

Medical illustration showing targeted therapy attacking lung cancer cells with EGFR mutations
New StudiesResearch Digest

Breakthrough Drug Shows 75% Response Rate in Hard-to-Treat Lung Cancer

Sunvozertinib achieved a 75% response rate in previously untreated lung cancer patients with EGFR exon 20 mutations, compared to 25%…

By
GMJ Research Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →